findmyKOL

Max Disse, MD

Basic profile

Dermatology

ORCIDNone on fileNPI
RegionDetroit Lakes, MN · MidwestSpecialtyDermatologyFocusDermatology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2021Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Max Disse is a Dermatology physician. OpenAlex indexes 5 publications with 347 citations (h-index 3).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
5publications

Distinct works indexed by OpenAlex.

347citations

Total citations across indexed works.

3h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
3companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

1245 Washington Ave
Detroit Lakes, MN 565013905

Telephone

218-846-2000

Provider last certified this registry record 25 Aug 2020.

View the NPPES registry record

Industry payments

3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Sensory organs

    25.9%
    Corticosteroid25.9%
    Clobetasol Propionate67%Betamethasone Dipropionate18%Hydrocortisone15%
    Part D73 patients
  • Dermatology

    22.9%
    Corticosteroid19.5%
    Triamcinolone Acetonide100%
    Part D111 patients
    Allylamine Antifungal2.1%
    Terbinafine Hcl100%
    Part D17 patients

    + 1 more class in this area

  • Anti-infectives

    17.7%
    Azole Antifungal6.2%
    Ketoconazole81%Fluconazole19%
    Part D<11 patients
    Nitroimidazole Antimicrobial3.9%
    Metronidazole100%
    Part D24 patients

    + 3 more classes in this area

Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”